Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00314756 · ClinicalTrials.gov registry record · Phase 4
Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage
A Phase 4 study, sponsored by Wake Forest University.
- Completed
- Registry status
- Phase 4
- Development phase
- 15
- Enrollment target
NCT00314756 is a Phase 4 study that has completed, run by Wake Forest University. The registered enrollment target is 15 participants.
The verdict
NCT00314756, a Phase 4 study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 15 participants
- Enrollment target
Study Summary
To assess the efficacy of treating a nodular basal cell carcinoma with imiquimod cream after initial treatment with curettage
Interventions
- DRUG imiquimod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2005-03 |
| Est. Completion | 2005-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00314756
The ClinicalTrials.gov registry entry for NCT00314756 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University, which has 100 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which imiquimod is the first listed.
NCT00314756 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00314756 about?
NCT00314756 is a clinical study titled "Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage". To assess the efficacy of treating a nodular basal cell carcinoma with imiquimod cream after initial treatment with curettage
What is the current status of trial NCT00314756?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 15 participants. The study started on 2005-03. Estimated completion is 2005-11.
What interventions are being tested in trial NCT00314756?
The interventions under investigation include: imiquimod (DRUG).
Who is sponsoring clinical trial NCT00314756?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.